JP2024527604A5 - - Google Patents
Info
- Publication number
- JP2024527604A5 JP2024527604A5 JP2024501696A JP2024501696A JP2024527604A5 JP 2024527604 A5 JP2024527604 A5 JP 2024527604A5 JP 2024501696 A JP2024501696 A JP 2024501696A JP 2024501696 A JP2024501696 A JP 2024501696A JP 2024527604 A5 JP2024527604 A5 JP 2024527604A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- independently selected
- substituted
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163222288P | 2021-07-15 | 2021-07-15 | |
| US63/222,288 | 2021-07-15 | ||
| PCT/US2022/036829 WO2023287793A1 (en) | 2021-07-15 | 2022-07-12 | Therapeutic compounds and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024527604A JP2024527604A (ja) | 2024-07-25 |
| JP2024527604A5 true JP2024527604A5 (enExample) | 2025-07-17 |
Family
ID=84919638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024501696A Pending JP2024527604A (ja) | 2021-07-15 | 2022-07-12 | 治療用化合物および方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US12006331B2 (enExample) |
| EP (1) | EP4370130A4 (enExample) |
| JP (1) | JP2024527604A (enExample) |
| KR (1) | KR20240036571A (enExample) |
| CN (1) | CN117642170A (enExample) |
| AR (1) | AR126470A1 (enExample) |
| AU (1) | AU2022309856A1 (enExample) |
| CA (1) | CA3226225A1 (enExample) |
| CL (1) | CL2024000114A1 (enExample) |
| CO (1) | CO2024001017A2 (enExample) |
| CR (1) | CR20240016A (enExample) |
| IL (1) | IL309878A (enExample) |
| MX (1) | MX2024000610A (enExample) |
| PE (1) | PE20240776A1 (enExample) |
| TW (1) | TW202317586A (enExample) |
| WO (1) | WO2023287793A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3226225A1 (en) | 2021-07-15 | 2023-01-19 | Genentech, Inc. | Therapeutic compounds and methods |
| WO2025082533A1 (zh) * | 2023-10-21 | 2025-04-24 | 上海轶诺药业有限公司 | 一种稠环化合物及其制备和应用 |
| EP4763280A1 (en) | 2024-12-19 | 2026-06-24 | Lead Discovery Center GmbH | Pharmaceutically active pyrazolo[5,1-c][1,4]benzoxazepine derivatives |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE267830T1 (de) * | 1999-08-27 | 2004-06-15 | Abbott Lab | Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen |
| CN1391476A (zh) * | 1999-09-27 | 2003-01-15 | 美国氰胺公司 | 血管升压素激动剂制剂和方法 |
| AR039475A1 (es) | 2002-05-01 | 2005-02-23 | Wyeth Corp | 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa |
| US20070232582A1 (en) | 2004-04-28 | 2007-10-04 | Wyeth Holdings Corporation | 4-substituted or unsubtituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as beta-lactamase inhibitors |
| EP3813805A4 (en) * | 2018-06-27 | 2021-08-25 | Children's Medical Center Corporation | INFLAMMATION INHIBITION COMPOUNDS |
| WO2020030613A1 (en) | 2018-08-07 | 2020-02-13 | Kemijski Institut | Small molecule-inhibitors of 6-phosphofructo-1-kinase for reducing lactate generation by cancer cells |
| CA3226225A1 (en) | 2021-07-15 | 2023-01-19 | Genentech, Inc. | Therapeutic compounds and methods |
-
2022
- 2022-07-12 CA CA3226225A patent/CA3226225A1/en active Pending
- 2022-07-12 EP EP22842759.7A patent/EP4370130A4/en active Pending
- 2022-07-12 IL IL309878A patent/IL309878A/en unknown
- 2022-07-12 JP JP2024501696A patent/JP2024527604A/ja active Pending
- 2022-07-12 CR CR20240016A patent/CR20240016A/es unknown
- 2022-07-12 WO PCT/US2022/036829 patent/WO2023287793A1/en not_active Ceased
- 2022-07-12 MX MX2024000610A patent/MX2024000610A/es unknown
- 2022-07-12 US US17/862,963 patent/US12006331B2/en active Active
- 2022-07-12 AU AU2022309856A patent/AU2022309856A1/en active Pending
- 2022-07-12 PE PE2024000068A patent/PE20240776A1/es unknown
- 2022-07-12 CN CN202280049669.2A patent/CN117642170A/zh active Pending
- 2022-07-12 KR KR1020247002069A patent/KR20240036571A/ko active Pending
- 2022-07-15 TW TW111126584A patent/TW202317586A/zh unknown
- 2022-07-15 AR ARP220101868A patent/AR126470A1/es unknown
-
2024
- 2024-01-12 CL CL2024000114A patent/CL2024000114A1/es unknown
- 2024-01-30 CO CONC2024/0001017A patent/CO2024001017A2/es unknown
- 2024-05-08 US US18/657,963 patent/US12459957B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3704096B1 (en) | Modulators of the integrated stress pathway | |
| AU2007284537B2 (en) | Triazole compounds that modulate HSP90 activity | |
| JP2024521979A5 (enExample) | ||
| KR101098584B1 (ko) | 세포괴사 저해제로서의 인돌 화합물 | |
| ES2395114T3 (es) | Derivados de triazinona y de diazinona útiles como inhibidores de Hsp90 | |
| ES2484042T3 (es) | Compuestos de triazol que modulan la actividad de HSP90 | |
| JP2023529354A5 (enExample) | ||
| SG11202111918PA (en) | Substituted cycloalkyls as modulators of the integrated stress pathway | |
| CA3080806A1 (en) | Modulators of the integrated stress pathway | |
| CA3080959A1 (en) | Modulators of the integrated stress pathway | |
| JP2009504764A5 (enExample) | ||
| JP2010510237A5 (enExample) | ||
| CA3080808A1 (en) | Modulators of the integrated stress pathway | |
| CA3080948A1 (en) | Modulators of the integrated stress pathway | |
| JP2018526399A5 (enExample) | ||
| JP2013507425A5 (enExample) | ||
| JP2008505902A5 (enExample) | ||
| JP2022525893A (ja) | Ｒｓｖ阻害剤としてのベンゾジアゼピン誘導体 | |
| CA2981499A1 (en) | Methods of administering glutaminase inhibitors | |
| JP2018536681A5 (enExample) | ||
| JP2023520462A5 (enExample) | ||
| JP2002517443A (ja) | Ｈｉｖプロテアーゼ阻害剤の浸透を増加させる方法および組成物 | |
| RU2010116779A (ru) | Производное амида индазолакриловой кислоты | |
| KR20120013266A (ko) | 세포괴사 저해제로서의 인돌 및 인다졸 화합물 | |
| KR20210039417A (ko) | 치환된 테트라하이드로사이클로펜타[c]피롤, 치환된 디하이드로피롤리진, 이의 유사체, 및 이의 사용 방법 |